158 related articles for article (PubMed ID: 8139147)
1. [Urinary cross-linked FDP in various renal diseases].
Inuma H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
[TBL] [Abstract][Full Text] [Related]
2. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
4. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
5. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
[TBL] [Abstract][Full Text] [Related]
6. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
[TBL] [Abstract][Full Text] [Related]
7. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
[TBL] [Abstract][Full Text] [Related]
9. Urinary crosslinked fibrin degradation products in glomerular disease.
Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
[TBL] [Abstract][Full Text] [Related]
10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
11. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
[TBL] [Abstract][Full Text] [Related]
12. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
13. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
[TBL] [Abstract][Full Text] [Related]
14. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
Hall CL; Blainey JD; Gaffney PJ
Nephron; 1979; 23(1):6-9. PubMed ID: 450168
[TBL] [Abstract][Full Text] [Related]
15. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
[TBL] [Abstract][Full Text] [Related]
16. [Fibrin degradation products in the urine in diabetic nephropathy].
Khristov V; Apostolov P; Stamenova T
Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
[TBL] [Abstract][Full Text] [Related]
17. Urinary fibrinogen and fibrin fragments in children with renal disease.
Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
[TBL] [Abstract][Full Text] [Related]
18. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
19. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
Astrug A; Shipkova P
Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
[TBL] [Abstract][Full Text] [Related]
20. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
Sakakibara K; Nagase M; Takada Y; Takada A
Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
